RankAlpha logo
Back to Rankings

CGON

CG OncologyC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
9
U.S. public peers
Grade Position
Below peers
vs peer average
CGON vs peer average
31/100
CGON vs. peer average (C vs. B)
Grade spread
A 2 · B 3 · C 1
Graded peers loaded
Coverage
8 graded
89% of tracked

Peer overview

FGEN is the first available peer comparator.

Company with targeted oncology assets and partnership-driven upside potential; comparable commercialization uncertainty.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerFGEN
CGON
CG Oncology
FGEN
Peer
Grade
C
-
Momentum
45
-
Value
41
-
Sentiment
64
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Unrated
Open Side-by-Side ComparisonCompare all

Grade position vs FGEN

CGON / FGEN
Grade Position
Below peers
CGON vs. peer average (C vs. B)
31/100
Momentum
45
-
Value
41
-
Sentiment
64
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CGON
1
FGEN
FGEN
-
-
-
2
LQDA
Liquidia Corp Common
A
100/100
-2
3
CRSP
CRISPR Therapeutics AG Common
B
80/100
-1
4
XENE
Xenon Pharmaceuticals Inc Common
C
60/100
Even
5
CAI
Caris Life Sciences Inc Common
N/A
-
-
FGEN is the first peer returned for this comparison set.